The Ellen and Andrew G Celli Foundation

NEW YORK, NY EIN: 13-4087933

The Ellen and Andrew G Celli Foundation is a private grantmaking foundation based in New York, NY. Designated as a 501(c)(3) organization, the foundation has been tax-exempt since December 1999. The foundation operates as a private foundation focused on philanthropic giving across multiple sectors.

Financial Overview

From 2025 IRS Form 990-PF · View filing

Total Assets

$468K

-10.6% YoY

Annual Giving

$69K

+9.4% YoY

Grant Count

-11.4% YoY

Avg Grant Size

$2K

+23.5% YoY

Under IRS private-foundation payout rules, The Ellen and Andrew G Celli Foundation reported a distributable amount of $25K for 2025 — the minimum it must pay out in qualifying distributions.

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

The foundation's grant-making priorities include:

Education
Philanthropy, Voluntarism & Grantmaking
Human Services

Grantmaking

Ready to take the next step with The Ellen and Andrew G Celli Foundation?

Assess fit for your org Draft an LOI Find open RFPs

Geographic Focus

Where this funder awards grants

Primary funding regions include New York, Massachusetts, and Pennsylvania.

Grant Distribution by State

New York $508K (86%)

Massachusetts $41K (7%)

Connecticut $29K (5%)

Pennsylvania $4K (1%)

District of Columbia $1K (0%)

Maine $1K (0%)

Tennessee $1K (0%)

Georgia $1K (0%)

+8 more states

States

California Connecticut District of Columbia Georgia Illinois Kansas Massachusetts Maryland Maine New Hampshire New Jersey New York Ohio Pennsylvania Tennessee Vermont

Cities

AnnandaleonhudsonAtlantaBala CynwydBaltimoreBostonBridgtonBristolBronxBrooklynBuffaloChicagoChilmarkDarienGambierGenevaGreenfieldLagrangevilleMamaroneckMiltonMurfreesboro

Financial History

Multi-year comparison from IRS filings

Most Recent Financial Data (2024):

Total Assets: $523,000
Revenue: $47,200
Expenses: $64,400
Total Liabilities: $154

Prior Year Data (2025 filing):

Total Assets: $467,897
Total Giving: $68,862

Revenue

Expenses

Qualifying Distributions

Net Investment Income

Metric	2025	2024	2023
Total Assets	$467,897	$523,421	$551,320
Revenue	$14,861	$47,177	$232,076
Expenses	$70,411	$64,429	$156,746
Qualifying Distributions	$68,962	$63,034	$154,639
Net Investment Income	$14,178	$47,177	$225,234
Distributable Amount	$25,126	$26,582	$23,036

Giving Over Time

Total grant dollars and number of grants per year

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2025

Grant Size Distribution

160 grants across all recorded years

Giving History

Grant recipients and amounts by year

Among its reported 2025 grants, the largest include Grand Street Settlement ($22,500), Reprieve Us Inc ($20,000), Martha's Vineyard Museum ($3,000).

Recipient	Purpose	Amount
ALZHEIMERS ASSOCIATION CHICAGO, IL	GENERAL CHARITABLE	$240
CHICKEN & EGG PICTURES BROOKLYN, NY	GENERAL CHARITABLE	$2,500
CHILMARK TOWN AFFAIRS CHILMARK, MA	GENERAL CHARITABLE	$1,000
CIRCUIT ARTS WEST TISBURY, MA	GENERAL CHARITABLE	$2,750
CITY PARKS FOUNDATION NEW YORK, NY	GENERAL CHARITABLE	$1,000
DOROT INC NEW YORK, NY	GENERAL CHARITABLE	$187
ETHICAL CULTURE FIELDSTON SCHOOL BRONX, NY	GENERAL CHARITABLE	$1,000
FILM AT LINCOLN CENTER NEW YORK, NY	GENERAL CHARITABLE	$1,000
FIVE BOROUGH INSTITUTE INC NEW YORK, NY	GENERAL CHARITABLE	$500
GALVANIZE USA WASHINGTON, DC	GENERAL CHARITABLE	$1,000

Leadership & Key People

Officers and directors from IRS filings

Compensation Overview

From 2025 IRS filing

From 2025 filing

Name	Title	Hours	Compensation
ELLEN UNTERBERG CELLI	PRESIDENT	0.5	—
ANDREW G CELLI JR	VICE PRESIDENT	0.5	—
EMILY SATLOFF	VICE PRESIDENT	0.25	—

Recent News & Activity

Recent developments and announcements

The foundation has supported research initiatives related to gastroesophageal cancer treatment, including funding for:

Grant Awarded to Improve Immunotherapy in Gastroesophageal Cancer

Novel cellular therapy development for gastroesophageal cancer

$750,000 Michael F. Price Grant Awarded to Move Novel Cellular Therapy for

Genetically engineered stem cell products to fight gastroesophageal cancer

Strides Made in Grant Awarded to Develop Genetically Engineered Stem Cell

Immunotherapy improvements in gastroesophageal cancer treatment

Grant Awarded to Improve Immunotherapy in Gastroesophageal Cancer

Contact Information

Address: 993 Park Avenue, Apt 5 South, New York, NY 10028-0922

EIN: 13-4087933

Subject Areas

Focus areas based on grantmaking activity

Philanthropy, Voluntarism & Grantmaking

Frequently Asked Questions

What does The Ellen and Andrew G Celli Foundation fund?

The foundation's grant-making priorities include: • Education • Philanthropy, Voluntarism & Grantmaking • Human Services

How do I apply for a grant from The Ellen and Andrew G Celli Foundation?

**Grant Amounts:** Typical awards range from $50,000 to $51,000. **Recent Giving Activity:** The foundation distributed $62,934 in total giving according to recent data, with $68,862 in total giving reported in the most recent filing. **Geographic Scope:** The foundation primarily funds organizations in New York, Massachusetts, and Pennsylvania.

Where does The Ellen and Andrew G Celli Foundation make grants?

Primary funding regions include New York, Massachusetts, and Pennsylvania.

What size grants does The Ellen and Andrew G Celli Foundation award?

In 2025, The Ellen and Andrew G Celli Foundation awarded 31 grants totaling $69K — an average of about $2K per grant, based on its IRS Form 990 filings.

How much is The Ellen and Andrew G Celli Foundation required to give away each year?

Private foundations must generally distribute about 5% of their assets annually. For 2025, The Ellen and Andrew G Celli Foundation reported a distributable amount of $25K on its IRS Form 990-PF — the minimum it must pay out in qualifying distributions.

What is The Ellen and Andrew G Celli Foundation's EIN?

The Ellen and Andrew G Celli Foundation's EIN (Employer Identification Number) is 13-4087933. IRS Form 990 filing data is available on this page for 2020–2025.